Senior partner attention on the decisions that actually move a supplement business — whether the subscription book is really profitable after churn, what a cGMP run costs versus a co-packer, how much compliance to budget, and how to be ready when an acquirer calls. Not generalist finance. Not a junior associate.

Talk to a CFO How it works

Why supplement CFOs need to be different

The CFO role carries the same title across industries. The daily priorities do not. A supplement CFO spends disproportionate time on a handful of things that don't appear in a SaaS or services CFO's calendar: a subscription book whose real value depends on churn nobody is watching closely enough, manufacturing economics where a co-packer's convenience trades against in-house margin, FDA and FTC compliance that costs real money and carries real risk, inventory that expires and must be batch-tracked, and an Amazon channel that can be half the revenue at a very different margin than DTC.

A generalist CFO hired into a supplement brand can read the P&L correctly and still miss what's happening underneath. The brand reporting a healthy blended LTV is often subsidizing a subscription cohort that churns hard after the second shipment. The brand chasing a lower per-unit cost commits to a manufacturing run larger than its expiry window can sell through. The brand scaling on Amazon is quietly running a different, thinner P&L than its DTC dashboard shows.

These aren't theoretical risks. They're the patterns we see repeatedly across supplement engagements. The right fractional CFO catches them in week one. The wrong one reads the P&L and moves on.

What a supplement CFO actually does

The 7 functions covered in every engagement.

1 — Subscription economics

The number that defines a supplement brand: subscription LTV after real churn, by cohort. We get it honest, then run the business off it. Churn vs LTV

2 — Unit economics & channel

CAC payback by channel and the Amazon-versus-DTC margin trade that decides where to scale. CAC + payback benchmarks · Amazon vs DTC

3 — Manufacturing & COGS

cGMP run cost, raw-active MOQs, and the co-packer versus in-house margin decision that gets harder as you scale. cGMP cost & COGS · co-packer vs in-house

4 — Pricing & AOV

Pricing built for subscription margin, and bundle and AOV strategy that raises order value without wrecking retention. Pricing for subscription margin · bundles & AOV

5 — Inventory & supply chain

Expiry-, batch-, and safety-stock-aware buys, plus where your nutraceutical COGS actually originates and what that means for tariff and supply risk. Expiry & batch inventory · import origins

6 — Compliance & governance

FDA and FTC compliance cost — structure-function claims, substantiation, cGMP testing — forecast and allocated, not discovered after a warning letter. FDA/FTC compliance cost

7 — M&A and exit prep

Supplements are an acquisitive category. We prepare 12–24 months ahead — clean books, defensible subscription cohorts, and an understanding of what drives the multiple. Who's acquiring supplement brands, and at what multiple

The supplement CFO's recurring decisions

Where the margin and cash actually move.

Each of these is a recurring decision in a supplement brand, and each has a dedicated breakdown with the math. This is the reading list we work through with a new supplement engagement.

Subscription, CAC, and the channel split

Supplements are a subscription business first, and the subscription book is only as good as its retention. A flattering blended LTV usually hides a cohort that drops off after the second or third shipment, and a CAC that looks fine on DTC can be underwater on Amazon. The CFO's job is to make the subscription economics honest, set the max CAC off real payback, and decide where the next marketing dollar should go.

Start here: subscription economics, churn versus LTV, CAC and payback benchmarks, and the Amazon versus DTC economics.

Pricing and order value

Price has to clear two bars in supplements: it has to fund acquisition on a subscription LTV, and it has to survive the discount expectations of a subscribe-and-save buyer. Bundles and AOV strategy can lift order value, but done wrong they cannibalize margin or accelerate churn. The CFO sets pricing that protects subscription contribution and uses bundles deliberately.

The math: how to price supplements for subscription margin and bundle and AOV strategy.

Manufacturing, COGS, and MOQs

Supplement COGS is driven by cGMP requirements, raw-active minimum order quantities, and the recurring co-packer-versus-in-house decision. A co-packer is fast and low-capital but caps your margin; in-house lifts margin but ties up cash and management. The right call changes with scale, and getting it wrong either strands cash in inventory or leaves margin on the table.

Go deeper: cGMP manufacturing cost and COGS and the co-packer versus in-house margin trade.

Inventory, supply chain, and compliance

Three areas where supplement CFOs quietly earn their fee. Inventory expires and must be batch-tracked, which forces tighter buys and real safety-stock discipline. Nutraceutical ingredients have specific origins that drive both COGS and tariff exposure. And FDA and FTC compliance — structure-function claims, substantiation, cGMP testing — is a real, forecastable cost, not a surprise.

The breakdowns: expiry, batch, and safety-stock inventory, where your supplement COGS actually lives, and what FDA and FTC compliance costs.

Preparing for an acquirer

Supplements are an acquisitive category, and buyers pay up for clean subscription cohorts and defensible retention. The brands that capture the top of the multiple range start preparing 12 to 24 months out, with the cohort reporting and add-back documentation a buyer will demand already in place.

The landscape and the math: who's acquiring supplement brands and what drives the multiple.

Outcomes

What changes in the first 12 months.

Most fractional CFO engagements at $10M+ supplement brands produce $200K–$600K of recoverable annualized contribution within the first year. At $30M+ that range climbs higher. In supplements specifically, the recovery tends to come from a predictable set of places.

Months 1–3: subscription truth and visibility

A weekly 13-week cash flow forecast goes live alongside honest subscription cohort reporting — retention, LTV, and payback by cohort, not blended. Monthly close lands inside 7–10 business days. Channel contribution gets split between DTC and Amazon for the first time at most brands, usually revealing that the two channels run very different P&Ls.

Months 4–6: margin, manufacturing, and inventory

Pricing and bundles get reset to protect subscription contribution. The co-packer-versus-in-house question gets modeled properly rather than assumed. Inventory buys get re-sized around expiry and MOQs, which frees cash and cuts write-offs. Compliance cost gets forecast and allocated instead of surfacing as surprises.

Months 7–12: capital and exit readiness

Capital structure gets cleaned up and growth gets funded against real subscription economics. For brands within 24 months of a sale, the exit prep starts: cohort and retention reporting, add-back documentation, and a working-capital target that won't get clawed back in diligence.

The pattern is consistent. The specific numbers vary by channel mix, retention, and starting state. We won't promise a number before scoping the engagement, but the ranges above are what we see.

Pricing

What it costs.

No proposal theatre. Engagement size depends on revenue, channel complexity, and scope. Here are the ranges across our active engagements in 2026.

$3M–$10M revenue

Strategic finance + cash management focus. Subscription cohort + inventory cash planning. Monthly close cadence.

$3,000–$6,000/mo

$10M–$30M revenue

Weekly senior partner cadence. Full 7-function scope. Channel margin + manufacturing optimization.

$6,000–$10,000/mo

$30M–$80M revenue

Senior partner + analyst layer. Board materials, capital strategy, retail + Amazon expansion modeling.

$8,000–$15,000/mo

$80M+ revenue or M&A active

Custom scope. Often includes seller-side QofE, capital structure work, or interim CFO bridge.

Custom

The economic case: one decision usually pays back the annual fee. A churn fix that lifts subscription LTV, a manufacturing run sized to the expiry window, or a clean exit that defends 10–25% of headline deal value — any one of those dwarfs the fee.

How we work

Weekly senior-partner cadence. No junior handoff.

Every engagement runs on the same operating rhythm. A weekly senior-partner call for tactical and strategic alignment. Analyst support for modeling and reporting. Monthly close review with variance commentary. Quarterly board materials. On-call availability for the decisions that don't wait — a manufacturing run, a financing offer, a compliance question.

The senior partner is the same person throughout. We don't hand off to associates for the recurring deliverables. The trade-off: we run fewer engagements concurrently than larger firms. The benefit: pattern recognition compounds, and the same brain that built your subscription model in month one is reviewing the variance in month twelve.

Related industry guides

Supplements sit inside the broader consumer-brand finance picture. If your model spans categories, these companion guides cover the adjacent mechanics: fractional CFO for ecommerce, fractional CFO for beauty brands, fractional CFO for CPG companies, and fractional CFO for Amazon FBA sellers. Tracking costs? See how fast supplement input costs are rising right now in our live DTC Input-Cost Index.

When NOT to hire us

Three scenarios. One, pre-revenue or under $1M — founder plus bookkeeper plus CPA is enough. Two, a single-SKU brand with no subscription book and no plans to grow or sell. Three, the CEO wants a yes-person. We tell brands what we see, and that sometimes includes "this subscription cohort isn't profitable" or "this manufacturing run is too big for your cash." If that's a problem, we're not the right fit.

FAQ

Frequently Asked Questions

What is a fractional CFO for a supplement brand?

A fractional CFO for a supplement brand is a senior finance partner who runs the CFO function part-time, typically 20 to 60 hours per month. They handle cash management, capital strategy, unit economics, and exit preparation, but they are specifically fluent in the mechanics that define supplements: subscription LTV and churn, cGMP manufacturing and co-packer COGS, FDA and FTC compliance cost, expiry-dated and batch-tracked inventory, and the Amazon-versus-DTC channel split that dominates the category.

How is a supplement CFO different from a generalist ecommerce CFO?

Same role, different daily decisions. A supplement CFO spends disproportionate time on subscription churn and LTV math, cGMP and co-packer cost versus in-house manufacturing, minimum order quantities on raw actives, FDA and FTC compliance cost including structure-function claim substantiation, expiry and batch-driven inventory buys, and the Amazon versus DTC margin trade. Those line items barely register for a SaaS or services CFO.

How much does a fractional CFO cost for a supplement brand?

Fractional CFO engagements for supplement brands typically run $3,000 to $15,000 per month depending on revenue, channel complexity, and scope. A $20M brand running a heavy subscription book across DTC and Amazon usually pays $6,000 to $10,000 per month for senior-partner attention plus analyst support. The economic case is simple: one correctly sized manufacturing run, or a churn fix that lifts LTV, typically pays back the annual fee.

When should a supplement brand hire a fractional CFO?

Most supplement brands benefit from a fractional CFO at around $5M revenue. Earlier triggers include a heavy subscription book that needs LTV and churn discipline, a move into Amazon or retail, a capital raise, or a planned sale within 12 to 24 months. Below $5M, a founder plus bookkeeper plus CPA usually suffices.

Can a fractional CFO help sell a supplement brand?

Yes, and it is a high-leverage use case given how acquisitive the supplement category is. A fractional CFO prepares 12 to 24 months ahead with accounting cleanup, subscription cohort and retention reporting buyers will scrutinize, EBITDA add-back documentation, working-capital target negotiation, and sometimes a seller-side Quality of Earnings audit. Brands that walk into diligence unprepared routinely lose 10 to 25 percent of headline deal value.

Does a supplement CFO handle FDA and FTC compliance cost?

The CFO does not file the regulatory paperwork, but they own the cost and cash impact of compliance. That includes cGMP facility and testing costs, FDA and FTC requirements around structure-function claims and substantiation, batch tracking that supports expiry-dated inventory, and how those costs are forecast, allocated to SKUs, and treated for EBITDA and valuation.

Next Step

Ready to talk to a CFO who actually operates in supplements?

30 minutes. We'll look at your subscription economics, your manufacturing and channel mix, and where the margin is leaking, and tell you upfront if we're not the right fit. No proposal theatre.

Talk to a CFO